Authorized for the cultivation of cannabis plants to produce narcotics for obtaining the necessary batches to validate the manufacturing process of narcotic active ingredients for medical purposes.


MEDICAL 
CANNABIS


Safe and effective natural treatment under medical prescription.


ELITE
QUALITY


Our flowers are special. Just wait and see.


PURITY &
POTENCY


Concentrations soar from 20% to 30% THC, packed with terpenes galore.



Understanding the evolution of medicinal cannabis in Europe.



Aspiring to be more than just another grower.




PIONEERING
MEDICAL CANNABIS


First indoor facility in Spain for batch validation, pioneering cannabis pharma in Europe.

PHARMA
CRAFT


Cold hang drying, dry trimming, slow curing, packed with protective gases.

WINNING
FORMULA


Small batches, high turnover, long-term stability.


OUR MISSION


Canamedics acknowledges the demand for top-tier medical cannabis flowers.
Our immediate goal is to surpass pharmaceutical validation and demonstrate why our manufacturing process can be considered an elite quality process. In the long-term, we aim to consistently provide products of the higher standards, meeting the market need for genuine quality.

OUR CONTRIBUTIONS
TO THE YEARS TO COME 



In the market's journey towards maturity, Canamedics Lab emerges as a producer who understands where the change is heading.

Flowers are the most prescribed medication in the European medicinal cannabis market.
However, since the market emerged, it has been inundated with ordinary flowers that adhere to the limits of monographs in their early stages of development.
Now, the medical flower market is maturing and transitioning towards potency, terpenes, high quality, reduced batch size and more product turnover with stability over time to enhance efficacy and overall patient experience.

PATIENT’S NEEDS



Each patient may respond differently. Each genetic variety of cannabis, produced in one way or another, can result in a different product with significant qualitative and quantitative variations in cannabinoids and terpenes. These differences can affect its efficacy and safety.

We will provide varieties of products to do our best to meet patients' needs, rather than expecting patients to adjust to our products. Our goal is to maintain consistent production for as long as patients demand.